To import or manufacture a new drug, a company has to seek permission from DCGI, the licensing authority by the filing Form 44 and submitting the requisite documents under Plan Y of the Drugs and Cosmetics Act 1940 and Rules 1945. Further, to prove its efficacy and be trustworthy among its consumers, it has to